A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)

Roche

Status: Completed

Conditions: Anemia, Kidney Disease, Chronic

Study type: Observational

Funder types: Industry

Identifiers

NCT01379963

ML22014

Details and patient eligibility

About

This retrospective observational study will evaluate the hemoglobin levels in patients with renal anemia over 6 months treatment with Mircera (methoxy polyethylene glycol-epoetin beta).

Enrollment: 780 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/= 18 years of age
• Renal anemia treated with Mircera for at least 6 months before entering study

Exclusion criteria

• Patients who refuse or are incapable of giving their written informed consent to retrospective data collection

Trial design

780 participants in 1 patient group

Cohort